BG1430U1 - Фармацевтично средство - Google Patents

Фармацевтично средство

Info

Publication number
BG1430U1
BG1430U1 BG1811U BG181110U BG1430U1 BG 1430 U1 BG1430 U1 BG 1430U1 BG 1811 U BG1811 U BG 1811U BG 181110 U BG181110 U BG 181110U BG 1430 U1 BG1430 U1 BG 1430U1
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical formulation
hifn
formulation
pharmacopoeial
stabilizers
Prior art date
Application number
BG1811U
Other languages
English (en)
Inventor
Иван ИВАНОВ
Геновева НАЧЕВА
Hans-Guenther Grigoleit
Original Assignee
Иван ИВАНОВ
Геновева НАЧЕВА
Hans-Guenther Grigoleit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иван ИВАНОВ, Геновева НАЧЕВА, Hans-Guenther Grigoleit filed Critical Иван ИВАНОВ
Priority to BG1811U priority Critical patent/BG1430U1/bg
Publication of BG1430U1 publication Critical patent/BG1430U1/bg

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Полезният модел се отнася до фармацевтично средство за потискане действието на ендогенния човешки гама интерферон (hIFN-гама) при заболявания, свързани с абнормена продукция на hIFN-гама, пo-специално автоимунни заболявания и посттрансплантна артериосклероза. То представлява лиофилна форма за парентерално приложение, включваща рекомбинантен протеин, фармакопейни буфери и стабилизатори.
BG1811U 2010-06-25 2010-06-25 Фармацевтично средство BG1430U1 (bg)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG1811U BG1430U1 (bg) 2010-06-25 2010-06-25 Фармацевтично средство

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG1811U BG1430U1 (bg) 2010-06-25 2010-06-25 Фармацевтично средство

Publications (1)

Publication Number Publication Date
BG1430U1 true BG1430U1 (bg) 2011-04-29

Family

ID=45877018

Family Applications (1)

Application Number Title Priority Date Filing Date
BG1811U BG1430U1 (bg) 2010-06-25 2010-06-25 Фармацевтично средство

Country Status (1)

Country Link
BG (1) BG1430U1 (bg)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US82138A (en) * 1868-09-15 Improvement in liquid-metees
WO1995030435A2 (en) * 1994-05-10 1995-11-16 Immulogic Pharmaceutical Corporation Compositions and treatment for multiple sclerosis
CA2361081A1 (en) * 1999-01-20 2000-07-27 The University Of Queensland Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US82138A (en) * 1868-09-15 Improvement in liquid-metees
WO1995030435A2 (en) * 1994-05-10 1995-11-16 Immulogic Pharmaceutical Corporation Compositions and treatment for multiple sclerosis
CA2361081A1 (en) * 1999-01-20 2000-07-27 The University Of Queensland Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis

Similar Documents

Publication Publication Date Title
MX421064B (es) Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm
EP4276180A3 (en) Clostridium histolyticum enzyme
NZ600709A (en) Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
CA2877521C (en) Cells for producing recombinant iduronate-2-sulfatase
NZ623294A (en) Stabilized alpha-galactosidase and uses thereof
WO2012047733A3 (en) Treatment of acne by conditioned media
NZ702801A (en) Treatment of sanfilippo syndrome type b
EP4218723A3 (en) Long-acting formulations of insulins
WO2012000103A8 (en) Methods of targeting pten mutant diseases and compositions therefor
EP4331620A3 (en) Lipidic nanoparticles for mrna delivery
NZ610556A (en) Stem cell suspension
MX2013002725A (es) Metodo para atenuar los efectos adversos del farmaco usando los acidos grasos omega-3 como un vehiculo terapeutico parenteral del farmaco.
NZ597580A (en) Polypeptides selective for alpha.v.beta.3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof
EP2558124A4 (en) POLYSACCHARID COMPOSITIONS AND METHOD FOR USE THEREOF FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH PRECURSOR CELL MOBILIZATION
WO2012115903A3 (en) Yeast strain for the production of proteins with modified o-glycosylation
BR112014021326A2 (pt) célula para a expressão de protéina, método para reduzir a atividade de amidação de peptídeo em uma determinada célula, uso de uma célula
MX392532B (es) Glicoproteinas recombinantes y sus usos.
IN2014DN05784A (bg)
BG1430U1 (bg) Фармацевтично средство
IN2014MN02461A (bg)
MX2012012489A (es) Preparacion de polipeptidos y sales de los mismos.
EP3065705A4 (en) Compositions and methods for administration of an enzyme to a subject's airway
WO2012129449A3 (en) High level production of recombinant proteins
IN2012CH03778A (bg)
WO2013023166A3 (en) Hapivirins and diprovirins